Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation

Tundra lists 1 Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT05815173

Ladarixin With Sotorasib in Advanced NSCLC

This is a phase I/II, open-label, study of twice-daily oral ladarixin with sotorasib in participants with advanced KRASG12C mutant non-small cell lung cancer (NSCLC).

Gender: All

Ages: 18 Years - 100 Years

Updated: 2025-12-30

1 state

Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation